We offer quantitative COVID-19 serology testing through our high-complexity CLIA laboratory. Our tests play a critical role in understanding immune response to vaccination and infection.
Our serology tests play a critical role in understanding immune response to vaccination and infection.
Better Understanding COVID-19Our tests measure antibodies that bind to the Receptor Binding Domain (RBD) of the spike protein of the SARS-CoV-2 virus.
View COVID-19 Serology Test MenuDownload forms to enroll as a provider and order tests.
View Order FormsLearn more about the advantages of quantitative serology testing and impact on health decisions.
Quantitative COVID-19 Serology FAQBillerica, MA, February 11, 2020: ProterixBio, Inc. announced today commercial availability of a quantitative COVID-19 serology assay that has been validated for dried blood spots (DBS) from a finger stick.…
Read MoreBillerica, MA, September 29, 2020: ProterixBio, Inc. announced today commercial availability of the SARS-CoV-2 (RBD) IgG Antibody test, a semi-quantitative COVID-19 serology assay. It is being offered as a testing…
Read More